INFECT – an INterface For Empirical antimicrobial ChemoTherapy
The INFECT Project, initiated by the INFECT Association, aims to support
healthcare professionals in treating patients with infectious diseases by providing intuitive access to
combined data on local antimicrobial resistance, pathogens and antibiotics. INFECT AMR is a web application
that imports anonymised patient susceptibility data, combines it with pathogen and antibiotics data, and
shows it in a substance-by-organism matrix, which users can filter according to various parameters.
The INFECT AMR Processor, a distributed real-time in-memory analytics engine, manages the computational load.
Users can filter data based on microbial, antimicrobial, or population attributes. Susceptibility is
represented as a coloured circle, and pathogens with relevant susceptibility only at increased exposure
and expected resistant or susceptible phenotypes are marked interactively.
The adaptable design of INFECT AMR permits adjustments to other data sources and the addition of supplementary modules.
To broaden access and support antimicrobial stewardship in a multitude of settings, the INFECT Association has
developed a web-based integrator platform, available at integration.infect.info,
which allows institutions and organisations to incorporate a partial INFECT AMR resistance matrix as a predefined
interactive widget in their web-based medical treatment guidelines or digital documents.
Benefit from a more comprehensive understanding of antimicrobial resistance patterns with our upcoming
feature that includes detailed resistance data alongside MIC (Minimum Inhibitory Concentration) distribution.
The MIC is a quantitative measure that represents the lowest concentration of an antimicrobial agent required
to inhibit the visible growth of a microorganism in vitro. This metric helps healthcare professionals
understand the susceptibility of a specific microorganism to different antimicrobial agents and aids in
selecting appropriate treatments.
The forthcoming guideline module widget promises seamless integration of third party evidence-based
antimicrobial treatment recommendations into existing platforms, starting with the INFECT 3.0 application.
This user-friendly addition will facilitate quick access to crucial guideline information, streamlining
workflows and improving patient care by ensuring that up-to-date treatment guidance is always within reach.
Standardised APIs to the widget may also support antimicrobial stewardship automation in the future.
Anticipate a transformative approach to treatment guidelines with our innovative INFECT guidelines framework.
This groundbreaking feature includes a widget configurator, allowing for customisation that meets your specific
needs. Furthermore, it incorporates structured data support to ensure seamless integration and compatibility
with various information systems, further enhancing the value of our platform.
Prepare for effortless integration of INFECT AMR and the INFECT Guidelines framework into modern healthcare
management systems using our new standardised APIs. Designed with interoperability in mind, these APIs
will facilitate seamless communication between systems, enabling healthcare providers to access critical
information, optimise workflows, and ultimately deliver better patient outcomes through data-driven decision-making.
Discover the Future of Antimicrobial Stewardship with INFECT - A SaaS Solution to Combat Antimicrobial Resistance
INFECT AMR is a tried and tested innovative application, which is also offered in a Software as a Service (SaaS) model
designed to empower nations and public health institutions in their fight against antimicrobial resistance. By
harnessing the power of advanced data analytics and intuitive design, INFECT AMR innovates the way countries can bring
their AMR data to the clinicians for their everyday use, supporting them with responsible antibiotic use and building
a sustainable healthcare system.
INFECT AMR has been successfully implemented in a pioneering country, demonstrating its effectiveness in combating the threat
of antimicrobial resistance. The results have been remarkable, paving the way for broader adoption and paving the way for
a future where AMR is effectively managed.
Join the revolution in antimicrobial stewardship and safeguard the future of medicine. Contact our team of experts to
learn how INFECT can help your nation combat the global threat of antimicrobial resistance.
This page is used to inform visitors regarding our policies with the collection, use, and disclosure of
Personal Information if anyone decided to use INFECT.
If you choose to use INFECT, then you agree to the collection and use of information in relation to this policy.
The Personal Information that we collect is used for providing and improving INFECT. We will not use or share
For a better experience, while using INFECT, we may require you to provide us with certain personally
identifiable information, including but not limited to the IP address. The information that we request
may collect data and information (also through third party products). This data may include information
such as your device IP address, device name, operating system version, the configuration of the app when
utilising INFECT, the time and date of your use of INFECT, and other statistics.
We may employ third-party companies and individuals to facilitate INFECT, to provide services on our behalf,
to perform INFECT-related services, or to assist us in analysing how INFECT is used. These third parties
may have access to your Personal Information.
We value your trust in providing us your Personal Information, thus we are striving to use commercially
acceptable means of protecting it. But remember that no method of transmission over the internet, or
method of electronic storage is 100% secure and reliable, and we cannot guarantee its absolute security.
These changes are effective immediately after they are posted on this page.
accordance with this policy.
notify you when cookies are being sent. Please note that disabling cookies may affect the functionality
and performance of the INFECT Application.
Application after any changes signifies your acceptance of those changes.
email@example.com or visit our Contact Us page on infect.org.
INFECT® and its logo are registered trademarks of the INFECT Association. All rights reserved. The use,
reproduction, or distribution of the INFECT name, logo, or any other related materials without the express
written consent of the INFECT Association is prohibited. Any unauthorised use of the INFECT trademark may
constitute a violation of applicable trademark laws and may result in legal action. Please contact the
INFECT Association for information on obtaining permission to use the trademark or related materials.
INFECT – in collaboration with its partners – maintains this website to enhance public access to information
about antibiotic resistance, treatment guidelines, antibiotic consumption, infection control and epidemiology.
Our goal is to keep this information timely and accurate and to minimise disruption caused by technical errors.
However, some data, information, content, or functions on our site may not be error-free and we cannot
guarantee that our service will not be interrupted or otherwise affected by such problems.
Therefore, INFECT specifically DISCLAIMS LIABILITY FOR INCIDENTAL OR CONSEQUENTIAL DAMAGES and assumes no
responsibility or liability for any loss or damage suffered by any person as a result of the use or misuse
of any of the information, content or function on this website or any linked external sites.
All information provided is:
Although INFECT is intended to be used to guide and support an optimal empirical antimicrobial therapy,
its use does not substitute a thorough investigation of patients’ signs and symptoms, or sound diagnostic
and therapeutic reasoning.